BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B

n vs succinic

Mechanistic comparison of n oxalylglycine and succinic acid based on molecular target overlap from BindingDB and ChEMBL binding affinity data.

2
Shared Targets
13%
Jaccard Similarity
12%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.

Evidence Comparison

n oxalylglycine
Evidence Score
0
PubMed Studies
View full profile →
succinic acid
Evidence Score
0
PubMed Studies
View full profile →

Target Overlap

n and succinic share 2 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.133 means 13% of the combined target set is bound by both compounds. The IDF-weighted score of 0.124 accounts for non-specific binding to metabolic enzymes.

Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.

Frequently Asked Questions

What do n and succinic have in common?
n and succinic share 2 molecular targets with a Jaccard similarity of 13%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can n and succinic be combined?
n and succinic share 2 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: n or succinic?
In the BiohacksAI corpus: n has 0 PubMed-indexed studies, succinic has 0 studies.

Related Comparisons

Similar to n

n vs vadadustat5 targetsn vs deferiprone3 targetsn vs rhein3 targetsn vs panobinostat3 targetsn vs roxadustat2 targets
View full n profile →View full succinic profile →Browse all substances →